Currently in development

The application we’re building

SeqAtlas brings genome and plasmid exploration, sequence editing, primers, cloning plans and result review into the same Mac workspace. Core analyses run locally, including searches against local reference sequences.

The capabilities page describes the development build: supported sequence and annotation inputs, CDS and protein extraction, assembly tools, Sanger review, CRISPR guide analysis, codon tools and export.

Development images

The screenshots are genuine examples of the work. Captions identify development views and the earlier browser interface. Older screenshots illustrate the sequence tools and do not represent the final Mac appearance.

What comes before public release

The next stage is to prepare the application for distribution and make its supported scope clear:

• Confirm macOS and processor requirements, installation and update arrangements.
• Document and test the formats and limits supported by each tool.
• Refine the Mac workflows and prepare practical user guidance.
• Publish the application’s privacy information, software terms and release details.
• Introduce download and subscription arrangements when they are ready.

Development priorities and the final release scope may change. Future availability will be announced here; no release date, subscription price or trial duration is being promised.

Inputs and interpretation

A format accepted by one tool may not be supported by every other tool. Annotation-dependent features need appropriate source annotations and matching sequence records. Analyses and predictions have method-specific limits.

Research use

SeqAtlas is being developed for research use. It is not intended for clinical diagnosis or treatment. Analysis and design outputs require independent checks and experimental validation.

For product or company enquiries, contact SEQATLAS LTD.